What’s on my mind this month is the new Shared Vision 2020 plan for University of Maryland Medicine, which is aimed to accelerate the pace of discovery, collaboration, innovation and quality of patient-centered care across the Medical School and Medical System. Our new vision is meant to position us for maximum and extraordinary success in the face of the challenging times upon us. Together with our UMMS partners, we have decided to apply strategic, bold and different approaches to all our key mission areas—education, clinical care, finance and philanthropy, and research.
Last month, we distributed a summary of our “Shared Vision 2020 for UM Medicine,” which I hope many of you have had a chance to review and share with your colleagues, students, staff and trainees. This special edition of SOMnews will focus on aspects of Vision 2020 that are specific to the School of Medicine, and some of the initiatives already under way.
Despite the current economic climate and uncertainties regarding the future of academic medicine in general, and research funding in particular, difficult times call for innovative thinkers who not only face challenges head-on, but welcome the opportunity to think strategically and think opportunistically. Although limited resources could be used as an excuse to make conservative decisions, true leaders need to make bold choices to avoid the pitfalls of inertia, which can easily lead to decline over time. This is why the key component of our Vision 2020 plan is to implement selective, strategic disruptive innovations across all our mission areas, starting in fiscal year 2014.
The impetus behind this initiative is to take the idea of “disruptive innovation,” coined by Clayton M. Christensen, MPhil, MBA, the Kim B. Clark Professor of Business Administration at Harvard Business School, and translate this idea, which was originally applied to the business world, into a driving principle for our Vision 2020. Christensen’s series of books on innovation and growth in the business, education and health care sectors ultimately concludes that good organizations fail because leadership places too much emphasis on the principles and practices that brought them success in the past (i.e., sustaining practices), rather than actively seeking or allowing room for “disruptive innovation.” Christensen defines disruptive innovation as a process by which a product or service takes root initially in simple applications at the bottom of a market and then relentlessly moves up in the market, eventually displacing established competitors. By analogy, we will use this technique to displace the obstacles we face as we plan our future.
Over the course of the next seven years, we will apply selective, strategic disruptive innovations as we strive to accomplish the following:
- In education, we will transform our teaching philosophy and educational “products” by promoting student-driven innovation and discovery.
- In clinical care, we will aim to become unquestionably the premier healthcare system for the State and region, distinguished by our clinical destination centers of excellence in many key areas.
- In finance and philanthropy, we will work to attain a philanthropic goal well in excess of $500,000 million through partnership, exploration of new revenue streams and strategic re-investment of reserve funding.
- In research, we will make discoveries that significantly change the direction of scientific research and health care by tackling “Big Science” questions through team science initiatives and research consortium units, accompanied by huge federal funding support.
In the past seven years we have seen extraordinary growth in virtually all mission areas, including an approximately 35 percent growth in total revenue, through increases in the number of grants and contracts, percentage of gifts, growth of the medical service plan, and other key areas. We have achieved top-tier status and have become a national leader in clinical and academic medicine, as well as biomedical research, by adopting a fierce, goal-oriented, aggressive, strategic and opportunistic approach to maximize our academic yield. While our historical performance will inform our efforts and help to shape us and influence our way forward, we cannot merely “rest on our laurels,” but need to adapt, modify and allow room for strategic disruptive innovations to continue our trajectory of success.
Vision 2020 is a culmination of ideas that came together through many discussions with senior staff, colleagues, ad-hoc advisory committees, and the input of the Research Affairs Advisory Committee. I am grateful for their invaluable assistance during the initial planning stages. However, now we need to put our philosophical position into practice and move Vision 2020 forward. The leadership cannot do this without the willingness of the entire SOM community to join us in this endeavor. The programs and initiatives you will read about in this special issue are just the beginning of how Vision 2020 can and will be implemented across the School.
As the summer comes to a close, and we turn our thoughts to the coming academic year, I hope these stories will serve to inspire and stimulate your own bold and strategic ideas for your academic unit.
In the relentless pursuit of excellence, I am
Sincerely yours,
E. Albert Reece, MD, PhD, MBA
Vice President for Medical Affairs, University of Maryland
John Z. and Akiko K. Bowers Distinguished Professor and
Dean, University of Maryland School of Medicine
Appointments
Kristin Atkins, MD, Assistant Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, has been named Director of Labor and Delivery Services at the University of Maryland Medical Center (UMMC), succeeding Lindsay Alger, MD, Professor, who is stepping down after 23 years of service.
Brian Berman, MD (pictured), Professor, Department of Family & Community Medicine, and Director, Center for Integrative Medicine, and Christopher D’Adamo, PhD, CPT, Professor, Department of Family & Community Medicine, and Director of Research, Center for Integrative Medicine, have been named Co-Directors of Maryland Hospitals for a Healthy Environment (MD H2E). Through its partnership with the Center for Integrative Medicine, MD H2E will continue to advance the culture of environmental health and sustainability in Maryland’s healthcare community, while providing new opportunities for physician education and engagement, research and outcomes evaluations, and further prevention of environmental exposures, by promoting integrative health and wellness.
Mordecai Blaustein, MD, Professor, Department of Physiology, has been elected as an honorary member of the Physiological Society by their Council of Trustees. He was formally welcomed at the Physiological Society 2013 annual meeting.
Daniel Bochicchio, MD, Clinical Assistant Professor, Department of Anesthesiology, has been appointed State Surgeon of the Maryland National Guard. The State Surgeon is the primary advisor to the Etate Adjutant General on military health issues, the medical readiness of the National Guard forces, and the guard’s ability to support civil authorities during disasters and other contingencies. Dr. Bochicchio has been in the Army National Guard since 1986 and completed two combat tours in Iraq.
Svetlana Chapoval, MD, PhD, Adjunct Assistant Professor, Department of Microbiology & Immunology, has been reappointed as Associate Editor of The Journal of Immunology for another two-year term.
Curt Civin, MD, Associate Dean for Research; Director, Center for Stem Cell Biology & Regenerative Medicine; and Professor, Departments of Pediatrics and Physiology, was inducted into the Baltimore Jewish Hall of Fame at the Gordon Jewish Community Center in Baltimore on June 12. The Jewish Hall of Fame celebrates Jewish Baltimoreans who have a made a difference in the fields of medicine, science, politics, law, education, business, community service, arts & entertainment, and beyond. Dr. Civin was honored for his contributions in the field of medicine for his work with stem cells, specifically his groundbreaking research that led to the development and implementation of both clinical bone marrow stem-cell transplantation and leukemia diagnosis. Created in 2008, the Baltimore Jewish Hall of Fame now has 38 members, including this year’s nine honorees. Dr. Civin is one of six physician members.
Vasken Dilsizian, MD, Professor, Department of Diagnostic Radiology & Nuclear Medicine, was elected to the position of Director-at-Large of the House of Delegates at the Society of Nuclear Medicine and Molecular Imaging scientific sessions, which were held in Vancouver, BC, June 8–12. He was also elected to serve as President of the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging. His term started July 1.
Vadim Morozov, MD, Assistant Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, has been appointed Director of the new University of Maryland Medical Center (UMMC) Program in Minimally Invasive Gynecologic Surgery.
Alina Grigore, MD, MHS, FASE, Associate Professor, Department of Anesthesiology, was named a Fellow of the American Heart Association by the Council on Cardiovascular Surgery and Anesthesia in May.
Stephen Reich, MD, the Frederick Henry Prince Distinguished Professor, Department of Neurology, has been named to the editorial board of the journal Parkinsonism and Related Disorders.
Lai-Xi Wang, PhD, Professor, Department of Biochemistry & Molecular Biology and Head of the Laboratory of Bioorganic Chemistry & Glycobiology at the Institute of Human Virology, was elected this past June in West Dover, VT, as Vice Chair and then Chair for the 2015 and 2017 Carbohydrate Gordon Research Conferences, respectively.
Events, Lectures & Workshops
Charles Chaffin, PhD, Associate Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, presented “How the Sugars That Fuel the Oocyte Are Regulated” to the Department of Biology at Loyola University Chicago in March. Also in March, Dr. Chaffin lectured on ovarian follicle growth at the “Frontiers in Reproductive Medicine” course sponsored by the University of Medicine and Dentistry of New Jersey.
Svetlana Chapoval, MD, PhD, Adjunct Assistant Professor, Department of Microbiology & Immunology, presented “Divergent Roles of Two Neuroimmune Semaphorins, Sema4A, and Sema4D In Regulation of Experimental Asthma Severity” at the Immunology-2013 meeting in Honolulu, HI, from May 3–7. She received a faculty travel award from the American Association of Immunologists to participate in this meeting.
Curt Civin, MD, Associate Dean for Research; Director, Center for Stem Cell Biology & Regenerative Medicine; and Professor, Departments of Pediatrics and Physiology, presented “The Progress and Vision of Stem Cell Research in Maryland” to the TEDCO Board of Directors in Columbia, MD, on May 16.
Howard Dubowitz, MD, MS, Professor, Department of Pediatrics, presented “Child Abuse and Neglect: A Suggested National Approach” before the Health and Welfare Committee in the Swedish Parliament in Stockholm on May 15. He also presented “Child Neglect: Controversies and Challenges” at Uppsala University in Sweden the following day.
Alan Faden, MD, the David S. Brown Professor in Trauma, Department of Anesthesiology, and Director of the Center for Shock, Trauma & Anesthesiology Research and the National Study Center for Shock and EMS, presented “Chronic Traumatic Encephalitis: Another Type of CTE” at Arrowhead’s 3rd Annual Traumatic Brain Injury Conference in Washington, DC, March 7; “Neuroprotection: Optimizing Animal Models” at the Round Table Conference “Neuroprotection: Clinical Aspects” in Brussels, Belgium, on March 16; and “New Neuroprotection Strategies” at the 33rd International Symposium on Intensive Care and Emergency Medicine in Brussels, Belgium, on March 19.
Gary Fiskum, PhD, the M. Jane Matjasko Professor for Research in Anesthesiology and Vice Chair of Research, Department of Anesthesiology, presented “The Roles of Mitochondria in Trauma” at the International Anesthesia Research Society Symposium, held in San Diego, CA, from May 4–7. He also presented “Roles of the Mitochondrial Membrane Permeability Transition Pore in Mediating Cell Injury and Cell Death” at the Society of Toxicology Symposium in Washington, DC, on May 13.
Stephen Reich, MD, the Frederick Henry Prince Distinguished Professor, Department of Neurology, was a plenary speaker at the annual meeting of the American Academy of Neurology in San Diego, CA, for the Controversies in Neuroscience session on “Should Levodopa Be Initiated at the Time of Diagnosis of Parkinson’s Disease?” At the same meeting, he also served as director of the course “Movement Disorders Therapeutics: A Case-Based Approach,” and was on the faculty for the course “The Dystonias: Diagnosis, Treatment, and Update on Causes.” He was also the senior author on a poster presented at the meeting: “Do Patients With Parkinsonism Use Properly Sized Canes?” Dr. Reich’s other recent presentations include “I’m So Dizzy: Managing the Older Adult with Acute Vertigo,” for the Edmund G. Beacham 40th Annual Current Topics in Geriatrics Course at Johns Hopkins on February 15; and “Facial Dyskinesias” at Neurology Grand Rounds at the University of Illinois, Peoria, IL, on April 26. He was also an invited speaker for Movement Disorders Video Rounds at The University of Cincinnati.
Adil Shamoo, PhD, Professor, Department of Biochemistry & Molecular Biology, gave a two-hour presentation on “Ethics in Science” at the Science Diplomats Club-Science Breakfast, held at the French Embassy in Washington, DC on May 29.
Gerald Wilson, PhD, Associate Professor, Department of Biochemistry & Molecular Biology, presented “Tumor Progression Directed by Re-Programming Post-Transcriptional Gene Regulatory Pathways” to the Department of Molecular Microbiology and Immunology at the St. Louis University School of Medicine in St. Louis, MO, on March 21. He also presented “Novel Protein and RNA Allosteric Regulators of Oncoprotein and Cytokine mRNA Decay” for the Division of Cancer Biology at the National Cancer Institute in Rockville, MD, on May 13.
Richard Zhao, PhD, Professor, Departments of Pathology and Microbiology & Immunology, was a co-chair for the scientific session “Translational Genomics and Anti-Cancer Therapy” at the 17th annual conference of the Chinese Biopharmaceutical Association (CBA-USA), which was held at the University of Maryland Shady Grove campus on June 15. Dr. Zhao was the President of this association from 2012–2013.
On June 29, 2013, in collaboration with the Department of Family & Community Medicine, faculty members from the Department of Dermatology presented a half-day of continuing medical education lectures for participants at the 2013 meeting of the Maryland Academy of Family Practice at the Clarion Hotel in Ocean City, MD. These lectures were on topics of interest to primary care doctors, such as birth marks in children, eczema, viral infections, melanoma and non-melanoma skin cancer, and effective use of dermatopathology in a primary care practice. Pictured together after the lectures (left to right) are Department of Dermatology faculty Linda Lutz, MD, Clinical Assistant Professor; Grace Kao, MD, Clinical Professor; Ronald Goldner, MD, Clinical Professor; Assembly Program Chair Shana Ntiri, MD, MPH (Assistant Professor, Department of Family & Community Medicine); Anthony Gaspari, MD, Professor and Chair; and Marcia Driscoll, MD, PharmD, Clinical Associate Professor.
Grants & Contracts
Eugene Albrecht, PhD, Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, received a four-year $2.43 million R01 research grant from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDKD) in April for “Primate Fetal Adrenal Development: Impact on Physiological Processes After Birth.” Dr. Albrecht and his team will study the impact of estrogen deprivation during primate pregnancy on the development of insulin insensitivity in offspring after birth. The study highlights the consequences of estrogen deprivation in human pregnancy (i.e. premature birth or exposure to endocrine disruptors), in increasing the risk of developing type 2 diabetes in offspring after birth.
Kelly Westlake, PhD, PT, has been awarded a 2013 UMB/UMCP Seed Grant for $65,000. Her application, entitled, “Independent Vector Analysis to Investigate Cognitive Neural Networks After Stroke: A Comparison between Two Rehabilitation Interventions,” was one of only six awarded out of a pool of 42.
Michal Zalzman, PhD, Assistant Professor, Department of Biochemistry & Molecular Biology, received a three-year, $600,000 Investigator-Initiated Grant from the Maryland Stem Cell Research Fund for “Rejuvenation of Human Adult Mesenchymal Stem Cells for Clinical Applications.”
Honors & Awards
Richard Colgan, MD, Professor, Department of Family & Community Medicine, was awarded the Western Maryland AHEC’s John M. Dennis Award on June 10. This award is presented in honor of the late John M. Dennis, MD, former Dean of the School of Medicine and former Vice Chancellor for Health and Academic Affairs at the University of Maryland, Baltimore. Recipients of this award are usually university representatives who have made noteworthy contributions to off-campus health professional education in Western Maryland through outstanding leadership, ingenuity and advocacy, and dedication.
Alan Faden, MD, is founder and editor of the journal Neurotherapeutics, which was recently named a “Rising Star” for its growing impact in the field of Neuroscience & Behavior, as calculated by Thomson Reuters Web of Knowledge’s “InCites/Essential Science Indicators” data file. InCites/Essential Science Indicators is a Web-based compilation of science indicators and trend data derived from the Thomson Reuters databases, focusing on highly cited papers, authors, organizations, journals, and nations across a variety of fields. “Rising Star” status is conferred based on an increase in citations as tracked during successive bimonthly updates to the InCites/Essential Science Indicators file. The latest increase for Neurotherapeutics surpassed that of any other journal in the field.
Alexandria Ganzermiller, MS, Director, Alumni Relations & Development, Department of Physical Therapy & Rehabilitation Science, received her Masters in Science in Communications Management from Towson University in June.
Misbah Khan, MD, MPH, Clinical Professor, Department of Pediatrics, has been awarded the 2013 Job Lewis Smith Award, which recognizes lifelong outstanding service in community pediatrics. She will be honored at the AAP National Conference and Exhibition (NCE) in Orlando, FL, in October. The Job Lewis Smith Award is presented to a pediatrician with a history of significant career achievements in community pediatrics. Nominees have a demonstrated history of achievements in one or more of the following areas: community pediatrics practice, research, advocacy, and training. “Given this criteria, it should come as no surprise that Misbah was chosen for such a prestigious award,” said Steven Czinn, MD, Professor and Chair.
Crystal Massie, PhD, OTR, an Academic Fellow on the University of Maryland Advanced Neuromotor Rehabilitation Research Training (UMANRRT) grant in the Department of Physical Therapy & Rehabilitation Science, is one of only seven selected to participate as a Fellow in the Young Investigators Symposium at the 2013 American Congress of Rehabilitation Medicine meeting “Progress in Rehabilitation Research,” to be held at the Walt Disney Resort in Florida from November 12–16.
Stephen Reich, MD, the Frederick Henry Prince Distinguished Professor, Department of Neurology, and his co-author, former Neurology Resident Dan Gold, DO, received the Resident and Fellow Writing Award from the journal Neurology for their 2012 paper “A 55-Year-Old Woman With Vertigo: A Dizzying Conundrum” (Neurology 2012;79:e146-52).
Erin Wright, CNM, Instructor, Department of Obstetrics, Gynecology & Reproductive Sciences, received the W Newton Long Award at the American College of Nurse-Midwives Annual Meeting in Atlanta. This award is given to support clinical research or activities that advance the profession of midwifery. Ms. Wright received her award to support her doctoral project on the use of integrative medicine techniques for stress reduction among midwives.
In the News
Ahmet Baschat, MB BCh, FACOG, Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, discussed his study of “Laser Treatments in Twin-to-Twin Transfusion Syndrome” in an interview with Reuter Health, which was published in the News Daily in late May.
Maureen Black, PhD, the John A. Scholl, MD, and Mary Louise Scholl, MD, Professor of Pediatrics, was quoted in The Baltimore Sun on May 28 in an article called “Crack Baby Epidemic Not as Bad as Originally Thought.” In this and other media appearance, including radio and news service interviews, Dr. Black spoke about her recent publication in Pediatrics regarding long-term outcomes in drug-addicted infants (a.k.a. crack babies).
Jessica Minacapelli, a Second-Year Student in the Department of Physical Therapy & Rehabilitation Science, was featured on Fox News on June 6 in a story regarding her grandfather’s decision to donate his body to science and how that decision was prompted by hearing Jessica’s account of her experiences in the DPT Anatomy lab.
New Faculty
Richard Benoit, MD, MPH, is joining the Department of Obstetrics, Gynecology & Reproductive Sciences as a Visiting Instructor in the Division of Maternal and Fetal Medicine this month. Dr. Benoit received his Doctor of Medicine degree from Brown University in 1996 and his Masters in Public Health from Yale University in 2003. He comes to Maryland from California, where he had been in private practice.
Patents & Inventions
Niharika Khanna, MBBS, MD, DGO, Associate Professor, Department of Family & Community Medicine, was awarded Patent # 8,440,648 on May 14, for “Methods and Compositions for Treatment of Intraepithelial Neoplasia.” Erimos Pharmaceuticals has been the lead on patent prosecution and, as such, will be handling the maintenance fees of the issued patent. The patent will be in effect until July 2, 2026.
Publications
Maureen Black, PhD, the John A. Scholl, MD, and Mary Louise Scholl, MD, Professor of Pediatrics, was among the co-authors on “Health of Children Classified as Underweight by CDC Reference But Normal by WHO Standard” in Pediatrics, 2013; 131 (6):e1780-7. Dr. Black and Stacy Buckingham-Howes, PhD, Postdoctoral Fellow; Sarah Shafer Berger, PhD, Postdoctoral Fellow; and Laura Scaletti, MA, Graduate Student, were among the co-authors on “Systematic Review of Prenatal Cocaine Exposure and Adolescent Development” in Pediatrics, 2013 Jun: 131(6):e1917-36. The latter paper attracted quite a bit of media attention, with Dr. Black being interviewed by newspapers and radio stations both locally and nationally.
Charles Chaffin, PhD, Associate Professor, Department of Obstetrics, Gynecology & Reproductive Sciences, was among the co-authors on “EGF-Like Ligands Mediate Progesterone’s Anti-Apoptotic Action on Macaque Granulosa Cells” in Biology of Reproduction, 2013 Jan 25;88(1):18.
Svetlana Chapoval, MD, PhD, Adjunct Assistant Professor, Department of Microbiology & Immunology, published the book chapter “Flow Cytometry-Based Analysis and Sorting of Lung Dendritic Cells” in InTech (ISBN 978-953-51-0626-5). She and Achsah Keegan, PhD, Professor, Department of Microbiology & Immunology, and Sergei Atamas, MD, PhD, Associate Professor, Department of Medicine, were co-authors on “Cytokines in Chronic Respiratory Diseases” in Faculty of 1000 Biology Reports, 2013;5:3.
Alicia Chaves, MD, Assistant Professor, Department of Pediatrics, was among the co-authors on “Infant Cardiac Magnetic Resonance Imaging Using Oscillatory Ventilation: Safe and Effective” in Pediatric Cardiology, 2013;34:1201-1205.
Curt Civin, MD, Associate Dean for Research; Director, Center for Stem Cell Biology & Regenerative Medicine; and Professor, Departments of Pediatrics and Physiology, was among the co-authors on “Artemisinin-Derived Dimer Phosphate Esters as Potent Anti-Cytomegalovirus (Anti-CMV) and Anti-Cancer Agents: A Structure-Activity Study” in Bioorganic & Medicinal Chemistry, 2013, April [Epub ahead of print]; and “FLT3-ITD Knockin Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to Myeloproliferative Neoplasm” in Cell Stem Cell, 2013, 11(3):346-58.
Vasken Dilsizian, MD, Professor, Department of Diagnostic Radiology & Nuclear Medicine, was among the co-authors on “Cardiovascular Imaging: What Was New in 2012?” in the Journal of the American College of Cardiology Cardiovascular Imaging, 2013 Jun;6:714-34.
Michael Donnenberg, MD, Professor, Department of Medicine, was among the co-authors on “An Escherichia coli Effector Protein Promotes Host Mutation Via Depletion of DNA Mismatch Repair Proteins” in mBio, 2013 Jun 18;4(3):e00152-13.
Richard Eckert, PhD, the John F.B. Weaver Distinguished Professor and Chair, Department of Biochemistry & Molecular Biology, was among the co-authors on “Protein Kinase C Delta Increases Kruppel-Like Factor 4 Which Drives Involucrin Gene Transcription in Differentiating Keratinocytes” in the Journal of Biological Chemistry, 2013, Apr 17 [Epub ahead of print].
Gary Fiskum, PhD, the M. Jane Matjasko Professor for Research in Anesthesiology and Vice Chair of Research, Department of Anesthesiology, was among the co-authors on “Anaesthetic Neurotoxicity and Neuroplasticity: An Expert Group Report and Statement Based on the BJA Salzburg Seminar” in the British Journal of Anaesthesia, 2013 May 30 [Epub ahead of print].
Carol Greene, MD, Professor, Department of Pediatrics, was invited to author the chapter on “Inborn Errors of Metabolism” in Medical Genetics in Pediatric Practice, recently published by the American Academy of Pediatrics.
Erik Lillehoj, PhD (pictured), Associate Professor; Wei Guang, MD, PhD, Research Associate; Hua Ding, BM, PhD, Research Associate; Steven Czinn, MD, Professor and Chair; and Thomas Blanchard, PhD, Associate Professor, all from the Department of Pediatrics, were among the co-authors on “Helicobacter pylori and Gastric Inflammation: Role of MUC1 Mucin” in the Journal of Pediatric Biochemistry, 2013;2(3):125-132.
Andrea Meredith, PhD, Associate Professor, Department of Physiology, was among the co-authors on “mitoBKCa is Encoded By the Kcnma1 Gene, and a Splicing Sequence Defines Its Mitochondrial Location” in the Proceedings of the National Academy of Sciences, 2013 Jun 10 [Epub ahead of print]. She was also among the co-authors on “Quantitative Localization of Cav2.1 (P/Q-type) Voltage-Dependent Calcium Channels in Purkinje Cells: Somatodendritic Gradient and Distinct Somatic Co-clustering with Calcium-Activated Potassium Channels” in the Journal of Neuroscience, 2013; Feb 20;33(8):3668-78; and “Olivocochlear Suppression of Outer Hair Cells In Vivo: Evidence for Combined Action of BK and SK2 Channels Throughout the Cochlea” in the Journal of Neurophysiology, 2013; Mar;109(6):1525-34.
Vincent Njar, PhD, Professor, Department of Pharmacology, and his lab personnel Puranik Purushottamachar, PhD, Research Associate; Lalji Gediya, PhD, Research Associate; Senthilmurugan Ramalingam, PhD, Postdoctoral Fellow; Andrew Kwegyir-Afful, MS, Graduate Student; and Marlena Martin, BS, Research Technician, were among the co-authors on “Systematic Structure Modifications of Multi-Target Prostate Cancer Drug Candidate Galeterone to Produce Novel Androgen Receptor Down-regulating Agents as an Approach to Treatment of Advanced Prostate Cancer” in the Journal of Medicinal Chemistry, 2013 Jun 27; 56(12): 4880-4898.
Maria Nurminskaya, PhD, Associate Professor, Department of Biochemistry & Molecular Biology, was among the co-authors on “Quercetin Attenuates Warfarin-Induced Vascular Calcification In Vitro Independently From Matrix Gla Protein” in the Journal of Biological Chemistry, 2013 Jan 25;288:2632-40.
E. Albert Reece, MD, PhD, MBA, Vice President for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, School of Medicine, and Zhiyong Zhao, PhD, Assistant Professor, both from Department of Obstetrics, Gynecology & Reproductive Sciences, were co-authors on the review article “New Concepts in Diabetic Embryopathy” in Clinical Laboratory Medicine, 2013 Jun;33(2):207-33.
Lai-Xi Wang, PhD, Professor, Department of Biochemistry & Molecular Biology and Institute of Human Virology, was among the co-authors on “Synthetic Glycopeptides Reveal the Glycan Specificity of HIV-Neutralizing Antibodies” in Nature Chemical Biology, 2013 Jun 30 [Epub ahead of print]. Dr. Wang was also among the co-authors on a related study, “Structural Basis for Diverse N-Glycan Recognition By HIV-1-Neutralizing V1-V2-Directed Antibody PG16” in Nature Structural & Molecular Biology, 2013 May 26 [Epub ahead of print].
Gerald Wilson, PhD, Associate Professor, Department of Biochemistry & Molecular Biology, was among the co-authors on “Post-Transcriptional Control of Gene Expression By AUF-1: Mechanisms, Physiological Targets, and Regulation” in Biochimica et Biophysica Acta, 2013 Jun-Jul;1829(6-7):680-8.